Related Experiment Video

Updated: Apr 23, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

14.7K

Aggravated DNA damage as a basis for enhanced glioma cell killing by MJ-66 in combination with minocycline

Mann-Jen Hour1, Wei-Ting Liu2, I-Chen Lu2

  • 1Graduate Institute of Pharmaceutical Chemistry and School of Pharmacy, China Medical University Taichung.

American Journal of Cancer Research
|September 19, 2014
PubMed

Insights

The synthetic quinazolinone analog MJ-66 induces glioma cell death by causing DNA damage and interfering with the G2/M checkpoint. Combining MJ-66 with Mino shows synergistic effects, offering a potential new therapy for malignant gliomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Malignant gliomas have a poor prognosis despite treatment advances.
  • Novel therapeutic strategies are needed to improve patient outcomes.

Purpose of the Study:

  • To investigate if the synthetic quinazolinone analog MJ-66 induces glioma cell death via DNA damage.
  • To explore the potential of MJ-66 as a therapeutic agent for malignant gliomas.

Main Methods:

  • Treatment of C6 glioma cells with MJ-66.
  • Analysis of DNA damage markers (γ-H2AX) and checkpoint proteins (Chk1, Cdc25C).
  • Evaluation of MJ-66, UCN-01 (Chk1 inhibitor), and Mino in vitro and in vivo glioma models.

Main Results:

  • MJ-66 treatment increased γ-H2AX levels and foci, indicating DNA damage.
  • MJ-66 disrupted the G2/M DNA damage checkpoint by affecting Chk1 and Cdc25C phosphorylation.
  • MJ-66 inhibited tumor growth and prolonged survival in glioma xenograft models.
  • Combination therapy with MJ-66 and Mino demonstrated synergistic effects on tumor inhibition and survival.

Conclusions:

  • MJ-66 induces glioma cell death through DNA damage and checkpoint interference.
  • The combination of MJ-66 and Mino represents a promising therapeutic strategy for malignant gliomas.
Keywords:
DNA damageGliomasbrain tumorminocyclinequinazolinone

More Related Videos

Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry08:21

Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry

Published on: September 1, 2019

12.3K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

19.9K

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K